Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #1149

    God morgen. 🙂

    1 Reply Last reply
    0
    • H Offline
      H Offline
      henrik48
      wrote on sidst redigeret af
      #1150

      God middag fra Oman 🙂

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #1151

        Just a moment...

        favicon

        (www.proinvestor.com)

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #1152

          Solsen det var godt nok noget af et peaksale - langt over hvad andre har ikke sandt

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #1153

            BofA i september om gen3013: We forecast DKK9.8bn ($1.5bn)
            2027E peak in-market sales, with a 10% probability to market.

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #1154

              Den enes død ... Ritzau: Nanoviricides, der har udviklet behandlinger for fugleinfluenza og hiv, stiger i formarkedet med 54,5 pct. til 8,45 dollar.

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #1155

                Ja JPM er voldsom positiv. 25% uden nærmest at se resultater fra valgt dosis er jo vildt.

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #1156

                  Men potentialet er der for de $5 bn. Men så skal data jo være supersuper gode.

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #1157

                    "Only one dose of daratumumab can decrease the amyloidogenic precursor immunoglobulin light chain protein rapidly and can lead to reversal of organ dysfunction in patients with AL amyloidosis" https://www.news-medical.net/news/20200127/Daratumumab-proves-effective-in-patients-with-relapsed-AL-amyloidosis.aspx

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      Plimsoller
                      wrote on sidst redigeret af
                      #1158

                      God morgen 🙂

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #1159

                        God morgen. 🙂

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          Parasitism
                          wrote on sidst redigeret af
                          #1160

                          God morgen 🙂

                          1 Reply Last reply
                          0
                          • T Offline
                            T Offline
                            transalp
                            wrote on sidst redigeret af
                            #1161

                            Go morgen.. 🙂

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #1162

                              Dr. Shah on Daratumumab-Based Regimens in Frontline Multiple Myeloma https://www.youtube.com/watch?v=nbzuqc5vM5M

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #1163

                                Chinese Dara dose escalation study Completed
                                https://clinicaltrials.gov/ct2/history/NCT02852837?A=24&B=25&C=merged#StudyPageTop

                                1 Reply Last reply
                                0
                                • L Offline
                                  L Offline
                                  lahn1
                                  wrote on sidst redigeret af
                                  #1164

                                  Mayo Dr. Sikander Ailawadh thinks maybe all MM patients needs two "shots" of CLR 131 before any other treatment. All MM patients receiving a split dosing af 37,5 ml CLR 131 in the ph2 Clover 1 trial had disease control and were progression free for 4 month and 50% with a ORR. Interesting to see if repeat dosing can extend durability. Video with Mayo Dr. from ASH commenting on CLR 131. https://www.youtube.com/watch?v=kHFmsr2_9cU&feature=youtu.be

                                  1 Reply Last reply
                                  0
                                  • SolsenS Offline
                                    SolsenS Offline
                                    Solsen
                                    wrote on sidst redigeret af
                                    #1165

                                    Marketcap på $24 mln er ikke meget for CLRB.

                                    1 Reply Last reply
                                    0
                                    • L Offline
                                      L Offline
                                      lahn1
                                      wrote on sidst redigeret af
                                      #1166

                                      Nej den er ikke ligefrem dyr. Clinical data call 19. feb med nyheder om deres ph2 cLR131 Clover trial. Kan forestille mig de vil teste repeat dosing noget mere end blot de 2 behandlinger i nuværende cohort.

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #1167

                                        Ritzau: Den amerikanske hedgefond AQR Capital Management har mindsket sin short-position i Genmab. Fonden har mandag nedbragt sin position til under 0,50 pct., eller nærmere bestemt 324.547 aktier, fra tidligere 0,58 pct.

                                        1 Reply Last reply
                                        0
                                        • J Offline
                                          J Offline
                                          JKY_VH
                                          wrote on sidst redigeret af
                                          #1168

                                          tak for den Bulder

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger